✦ LIBER ✦

Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestine

✍ Scribed by Niklas Zar; Hans Garmo; Lars Holmberg; Per Hellman

Book ID: 116429533
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 158 KB
Volume: 44
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2007.12.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of second primary malignancies in p

Risk of second primary malignancies in patients with cutaneous melanoma

✍ M-H. Schmid-Wendtner; J. Baumert; C-M. Wendtner; G. Plewig; M. Volkenandt 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

549 Causes of death and risk of secondar

549 Causes of death and risk of secondary malignant tumours in patients with malignant tumours of the small bowel

✍ N. Zar; J. Rastad; J. Yuen; L. Holmberg 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Combination chemotherapy with cisplatin

Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine

✍ Makiko Ono; Kuniaki Shirao; Atsuo Takashima; Chigusa Morizane; Natsuko Okita; Da 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 174 KB

Second primary malignancies in patients

Second primary malignancies in patients with cancer of the head and neck

✍ Pedro Vaamonde; Carlos Martín; María Del río; Torcuato Labella 📂 Article 📅 2003 🏛 SAGE Publications 🌐 English ⚖ 117 KB

Causes and risk factors of death in pati

Causes and risk factors of death in patients with thrombotic microangiopathies

✍ Peigne, Vincent; Perez, Pierre; Resche Rigon, Matthieu; Mariotte, Eric; Canet, E 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 298 KB

Risks of second primary malignancy in pa

Risks of second primary malignancy in patients with cutaneous and ocular melanoma in denmark, 1943–1989

✍ A. J. Swerdlow; H. H. Storm; P. D. Sasieni 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 780 KB

Risks of 2nd primary cancer were assessed in all patients with cutaneous melanoma (I 2,460) and all patients with ocular melanoma (2,O 18) incident in Denmark from I943 to I989 and followed for totals of 88,667 person-years and 16,045 personyears, respectively. After cutaneous melanoma, 972 2nd canc